(CME Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium
Community Practice Connections™: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm
Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options
Community Practice Connections™: Ophthalmology Times® EyeCon 2022
Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life
Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options
Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment
(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden
COPHy 2023: Traveling the path to new restorative therapiesMarch 24th 2023
In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
Ophthalmology practice agrees to pay more than $2.9 million to settle kickback allegationsMarch 24th 2023
The U.S. Attorney' Office Eastern District of Texas reported Kleiman Evangelista Eye Centers has agreed to pay $2,902,505 to resolve False Claims Act allegations that it offered and paid kickbacks to optometrists. In a statement, the practice said it settled the the civil action to avoid a protracted legal battle and remains committed to optimizing patient outcomes while continuing to work with its patients’ valued optometrists when patients choose to have their care co-managed.
COPHy 2023: Durability associated with multi-target therapies is superior to anti-VEGF mono-target therapy in AMDMarch 24th 2023
Antonio Campos, MD, PhD, discusses his position on a discussion titled Durability Associated with Multi-target Therapies is Superior to anti-VEGF Mono-target Therapy in AMD with David Hutton, Executive Editor, Ophthalmology Times.®
VLOG: Unilateral isolated paucisymptomatic optic disc edema - what is that?March 23rd 2023
On this week's episode of the NeuroOp Guru video blog, Andy Lee, MD, and Elizabeth Fortin, MD, discuss unilateral isolated paucisymptomatic optic disc edema and what exactly it is.